Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses is a research paper published in Nature (2021). On theSindex it has a DataRank of 0.844. It has been cited 277 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.844
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIAID NIH HHS
Grant: F32 AI152296
NIAID NIH HHS
Grant: R01 AI157155
NIAID NIH HHS
Grant: T32 AI007151
NCI NIH HHS
Grant: U54 CA260543
NIH HHS
Grant: P40 OD012217
NIH HHS
Grant: U42 OD021458
NIAID NIH HHS
Grant: UC6 AI058607
NIAID NIH HHS
Grant: U19 AI142596
National Institutes of Health
Grant: 5R01AI157155-02
Human antibody-based countermeasures against the Coronavirus SARS-CoV-2
National Institutes of Health
Grant: 1UC6AI058607-01
Regional Biocontainment Laboratory (RBL)
National Institutes of Health
Grant: 1F32AI152296-01A1
Defining viral and immune mechanisms of Dengue virus serotype 2 immune evasion
National Institutes of Health
Grant: 5T32AI007151-42
Infectious Disease Pathogenesis Research Training Program
National Institutes of Health
Grant: 4U54CA260543-02
North Carolina Seronet Center for Excellence
National Institutes of Health
Grant: 5U19AI142596-03
Messenger RNA Immunogens for initiation of protective HIV non-neutralizing antibodies
FWCI
14.85
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Double-layered N-S1 protein nanoparticle immunization elicits robust cellular immune and broad antibody responses against SARS-CoV-2
Additional file 1 of Double-layered N-S1 protein nanoparticle immunization elicits robust cellular immune and broad antibody responses against SARS-CoV-2
Additional file 1 of RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine
Additional file 1 of RBD-specific antibody responses after two doses of BBIBP-CorV (Sinopharm, Beijing CNBG) vaccine